Bill
Bill > A3265
summary
Introduced
01/13/2026
01/13/2026
In Committee
01/13/2026
01/13/2026
Crossed Over
Passed
Dead
Introduced Session
2026-2027 Regular Session
Bill Summary
This bill establishes certain data reporting requirements for hospitals, so that the Division of Consumer Affairs (division) in the Department of Law and Public Safety can study, and annually report on, emerging trends in prescription drug pricing in hospitals. Current law requires pharmacy benefits managers, wholesale drug distributors, insurance issuers, and manufacturers to register with the division and report certain data to the division concerning prescription drug transactions. This bill extends similar reporting requirements to hospitals and includes hospitals as reporting entities subject to certain requirements under P.L.2023, c.106. Under this bill, hospitals will, to the extent allowed by law, report to the division the following minimum data, and other data that may be specified by the division. The division will annually notify hospitals for which specific drugs or drug groups for which reporting is required and a hospital shall have 60 days following such notification to report to the division the following: (1) minimum and maximum price paid for each indicated drug and drug group in the last calendar year, related to prescriptions under an insurance policy issued in the State; (2) volume in pricing units of each indicated drug and drug group that the hospital dispensed or administered in the last calendar year, for business in the State, in total and for each payer type as relevant; (3) total rebates, discounts, and price concessions received for each drug and drug group as indicated by the division in the last calendar year, for business in the State, in total and for each payer type as relevant; and (4) total net income received in the last calendar year for each drug and drug group as indicated by the division, for business in the State, in total and for each payer type as relevant. Disclosure of all information reported under this bill will be subject to protections under P.L.2023, c.106.
AI Summary
This bill requires hospitals to report specific data to the Division of Consumer Affairs (division) within the Department of Law and Public Safety, enabling the division to study and report on emerging trends in prescription drug pricing within hospitals. This expands upon existing law that already mandates reporting from pharmacy benefits managers, wholesale drug distributors, insurance issuers, and manufacturers. Hospitals will be required to report, upon notification from the division about specific drugs or drug groups, the minimum and maximum prices paid, the volume dispensed or administered, total rebates and discounts received, and total net income for those drugs over the past calendar year, with all reported information protected from public disclosure. Hospitals are also now explicitly defined as "reporting entities" and will be subject to the same registration, potential penalties for non-compliance, and annual assessment fees as other entities under the existing law, P.L.2023, c.106, which established these reporting requirements.
Sponsors (1)
Last Action
Introduced, Referred to Assembly Health Infrastructure Committee (on 01/13/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2026/A3265 |
| BillText | https://pub.njleg.gov/Bills/2026/A3500/3265_I1.HTM |
Loading...